OTRIMED Trademark

Trademark Overview

On Thursday, July 12, 2012, a trademark application was filed for OTRIMED with the United States Patent and Trademark Office. The USPTO has given the OTRIMED trademark a serial number of 85674802. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, June 21, 2023. The OTRIMED trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

conducting human clinical trials in the field of medicine for others, namely, biopharmaceuticals and medical device companies
otrimed

General Information

Serial Number85674802
Word MarkOTRIMED
Filing DateThursday, July 12, 2012
Status800 - REGISTERED AND RENEWED
Status DateWednesday, June 21, 2023
Registration Number4437302
Registration DateTuesday, November 19, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 11, 2012

Trademark Statements

Goods and Servicesconducting human clinical trials in the field of medicine for others, namely, biopharmaceuticals and medical device companies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 19, 2012
Primary Code042
First Use Anywhere DateThursday, February 2, 2012
First Use In Commerce DateTuesday, May 1, 2012

Trademark Owner History

Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressEdgewood, KY 41017
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressEdgewood, KY 41017
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressEdgewood, KY 41017

Trademark Events

Event DateEvent Description
Wednesday, June 21, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, June 21, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, June 21, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, June 21, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 21, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, November 19, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, January 14, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, January 14, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, October 27, 2019TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, August 12, 2019POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Monday, August 12, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 1, 2019TEAS SECTION 8 & 15 RECEIVED
Sunday, December 16, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, December 16, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 19, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 19, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, October 16, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 15, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, October 15, 2013ASSIGNED TO LIE
Monday, September 30, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 10, 2013STATEMENT OF USE PROCESSING COMPLETE
Monday, August 5, 2013USE AMENDMENT FILED
Friday, August 30, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 5, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, February 5, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 11, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 11, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 21, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 6, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 5, 2012ASSIGNED TO EXAMINER
Thursday, July 19, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 16, 2012NEW APPLICATION ENTERED

Related Keywords

otrimed biopharmaceuticals namely medical device companies others medicine human clinical trials